Cleared Traditional

K052289 - DEEPWAVE NEUROMODULATION PAIN THERAPY D...

K052289 is an FDA 510(k) clearance for DEEPWAVE NEUROMODULATION PAIN THERAPY D..., manufactured by Biowave Corporation. The device is a Class 2 Neurology device with product code LIH cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K052289 · Biowave Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
112d
Days
Class 2
Risk

K052289 is an FDA 510(k) clearance for the DEEPWAVE NEUROMODULATION PAIN THERAPY DEVICE. Classified as Interferential Current Therapy (product code LIH), Class II - Special Controls.

Submitted by Biowave Corporation (North Attleboro, US). The FDA issued a Cleared decision on December 13, 2005 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Biowave Corporation devices

FDA 510(k) Submission Details - K052289

510(k) Number K052289 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 2005
Decision Date December 13, 2005
Days to Decision 112 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 148d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIH Device Classification - Class 2, Special Controls

Product Code LIH Interferential Current Therapy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LIH Interferential Current Therapy

All 30
Devices cleared under the same product code (LIH) and FDA review panel - the closest regulatory comparables to K052289.
ETD4000
K202725 · Therasigma, LLC · Mar 2021
Avid IF2
K183692 · Vision Quest Industries Inc./Dba VQ Orthocare · Jun 2019
EVERYWAY INTERFERNTIAL STIMULATOR, MODEL IF-908
K110509 · Everyway Medical Instruments Co.,Ltd · Jun 2011
INFINITY ELECTROTHERAPY SYSTEM
K042057 · Empi · Dec 2004
INTERFERENTIAL STIMULATOR, MODEL BMLS02-6
K040007 · Biomedical Life Systems, Inc. · Jul 2004
INTERFERENTIAL STIMULATOR, MODEL BMLS03-6
K040824 · Biomedical Life Systems, Inc. · Apr 2004